We are live on ! Find out more
COCHW icon

Envoy Medical Warrant
COCHW

56 hedge funds and large institutions have $2.77M invested in Envoy Medical Warrant in 2022 Q2 according to their latest regulatory filings, with 10 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

50% more repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 2

43% more first-time investments, than exits

New positions opened: 10 | Existing positions closed: 7

6% more funds holding

Funds holding: 5356 (+3)

30% less capital invested

Capital invested by funds: $3.94M → $2.77M (-$1.17M)

Holders
56
Holders Change
+3
Holders Change %
+5.66%
% of All Funds
0.94%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
10
Increased
3
Reduced
2
Closed
7
Calls
$6.99M
Puts
Net Calls
+$6.99M
Net Calls Change
-$173K

COCHW Hedge Fund Activity: Q2 2022 in Review

56 of the 5,937 institutional investors tracked by Wall St. Rank reported a position in Envoy Medical Warrant (COCHW) for Q2 2022, worth a combined $2.77M — down 30% from $3.94M a quarter earlier.

Buyers outnumbered sellers: 10 funds opened new COCHW positions and 7 closed out — a net gain of 3 holders — while 3 added to existing stakes and 2 trimmed.

The largest buyer was Parallax Volatility Advisers, adding an estimated $36.5K. The largest seller was Man Group, exiting entirely with an estimated $54.3K sold.

  • 56 institutional investors held Envoy Medical Warrant (COCHW) as of Q2 2022, up from 53 in Q1 2022.
  • Funds reported $2.77M of Envoy Medical Warrant stock for Q2 2022, down 30% quarter-over-quarter.
  • 10 funds opened new Envoy Medical Warrant positions in Q2 2022 and 7 closed out, a net change of +3 holders.
  • The largest Envoy Medical Warrant buyer in Q2 2022 was Parallax Volatility Advisers, an estimated $36.5K added.
  • The largest Envoy Medical Warrant seller in Q2 2022 was Man Group, an estimated $54.3K sold.

Based on aggregated 13F filings for Q2 2022.